Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of DWP-450 for Glabellar Lines
NCT02184988Phase 2Completed
- Sponsor
- Evolus, Inc.
- Start
- Aug 2014
- Primary completion
- Dec 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of prabotulinumtoxinA in glabellar lines, sponsored by Evolus, Inc.. Started Aug 2014; status: completed.
02
Drugs
prabotulinumtoxinA
03
Conditions
glabellar lines
Beyond the preview
Go deeper on NCT02184988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02184988.